Skip to main content
Year archive

CompuGroup Medical SE & Co.KGaA — 2023 filings

All 31 regulatory filings released by CompuGroup Medical SE & Co.KGaA (COP) in 2023, sourced directly from the official regulator.

31 Filings
2023 Period
2023 filings (31)
Filing Released Lang
CGM registers significant increase in issued e-prescriptions
Regulatory Filings
2023-12-14 English
CompuGroup Medical SE & Co. KGaA: Dr. Ulrich Thome, Acceptance of 250,000 stock options to subscribe to one share each of CompuGroup Medical SE & Co. KGaA as part of the participation as ...
Director's Dealing
2023-11-10 English
CGM continues to drive digitization in healthcare and reports 10 % revenue growth in first nine months
Earnings Release 9M 2023
2023-11-09 English
Q3 statement / Q3 financial report 2023
Interim / Quarterly Report 9M 2023
2023-11-09 German
CompuGroup Medical successfully places Schuldschein of EUR 300 million
Capital/Financing Update
2023-10-16 English
CompuGroup Medical bundles data-based solutions with ambulatory information systems and appoints Daniela Hommel as CFO
Board/Management Information
2023-10-05 English
CompuGroup Medical SE & Co. KGaA: Michael Rauch, buy
Director's Dealing
2023-09-29 English
CompuGroup Medical SE & Co. KGaA: Julius Fynn Rauch, buy
Director's Dealing
2023-09-11 English
CGM reports on growth initiatives and proprietary AI tool at Capital Markets Day
Regulatory Filings
2023-09-07 English
CompuGroup Medical SE & Co. KGaA: Justus Mats Rauch, buy
Director's Dealing
2023-08-18 English
CompuGroup Medical SE & Co. KGaA: Magnus Tim Rauch, buy
Director's Dealing
2023-08-18 English
CompuGroup Medical launches AI initiative improving healthcare IT products and solutions
Earnings Release H1 2023
2023-08-10 English
CompuGroup Medical delivers excellent profitable growth in second quarter
Earnings Release Q2 2023
2023-08-10 English
Half-yearly financial report 2023
Interim / Quarterly Report H1 2023
2023-08-10 German
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
Audit Report / Information FY 2023
2023-07-26 German
Report Publication Announcement 2023
Report Publication Announcement
2023-07-12 English
CompuGroup Medical SE & Co. KGaA: Michael Rauch, buy
Director's Dealing
2023-07-05 English
CompuGroup Medical SE & Co. KGaA: Dr. Eckart Pech, Acceptance of 30,000 stock options to subscribe to one share each in CompuGroup Medical SE & Co. KGaA as part of the participation in the stock ...
Director's Dealing
2023-07-03 English
CompuGroup Medical SE & Co. KGaA: Hannes Reichl, Acceptance of 20,000 stock options to subscribe to one share each in CompuGroup Medical SE & Co. KGaA as part of the participation in the stock ...
Director's Dealing
2023-07-03 English
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Notice of Dividend Amount
2023-07-03 German
Q1 statement / Q1 financial report 2023
Earnings Release Q1 2023
2023-05-25 English
CGM appoints Michael Rauch as CEO and reports on successful financial year and board changes at virtual AGM
AGM Information
2023-05-17 English
CompuGroup Medical Administrative Board appoints Michael Rauch as CEO
Board/Management Information
2023-05-17 English
CompuGroup Medical SE & Co. KGaA: Emanuele Mugnani, buy
Director's Dealing
2023-05-10 English
CompuGroup Medical with 16% revenue growth in the first quarter
Earnings Release Q1 2023
2023-05-10 English
CompuGroup Medical acquires majority stake in patient portal provider m.Doc
M&A Activity
2023-04-24 English
CGM proposes dividend on prior years level to be passed at virtual AGM in May
Notice of Dividend Amount
2023-04-03 English
CompuGroup Medical SE & Co. KGaA: Bekanntmachung der Einberufung zur Hauptversammlung am 17.05.2023 in Koblenz, virtuell mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2023-04-03 German
Annual financial report 2022
Annual Report FY 2022
2023-03-24 English
Report Publication Announcement 2023
Report Publication Announcement
2023-03-23 English
CompuGroup Medical SE & Co. KGaA: CGM in 2022 with double-digit revenue growth strong 2023 guidance underlines mid-term ambitions
Earnings Release FY 2022
2023-02-09 English